🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

“The start-up data can be indicative of emerging clusters, with the greater Birmingham area and Bristol notable.” Find out more about the changes taking place within the life science industry. Click the link below. wapg.co/reports #LifeSciences #LSR2022 @JLLUK

How can you best plan your #IP strategy? This was covered at #BioIntegrates with panellists from ProductLife Group, Transine Therapeutics, Incubate bio, J A Kemp & @Uniofeicester Panel leader James Fry, Mills & Reeve, has put together an insightful report: lifescienceintegrates.com/protect-at-all…

We're pleased to announce that PhoreMost has entered into a multi-project #targetdiscovery #collaboration with Roche. Our SITESEEKER platform will be deployed to identify novel targets for Roche’s discovery programmes. Read the announcement here: rb.gy/csxcsb

What are the pros & cons of an Established vs Unique Combinational Product Platform? Join us at #MedTechIntegrates for discussion of speed, costs, regulations and more with an expert panel from Smithers CPI Element Materials Technology Medical Sports Team Vectura Group Viatris

Join Angie Morley and guests as we explore the E in ESG. We’ll discuss the key sustainability issues that impact Mills & Reeve as an organisation, our people, clients and the wider communities that we serve. #esg #environmental #sustainability pbynd.co/yw4fp

Our September edition of Sequence, our #lifesciences legal newsletter, is available now. To receive future editions, sign up to My M&R: mills-reeve.com/my-mr/register pbynd.co/cgecv

A #patent application for an app to support patient compliance failed to meet the EPO's standards. pbynd.co/mgn42

The UN’s Intergovernmental Panel on Climate Change said global warning has become a “code red for humanity”. With temperatures at unprecedent levels of 40 degrees in July, is the UK’s life sciences sector doing enough to prevent figures becoming the norm? pbynd.co/42wat

The UK is planning a 12-month extension to its planned reforms of medical device regulation, and a new approach to providing effective regulation for the growing software and AI medical device sectors. What can businesses expect? pbynd.cc/nfuxk

Our #lifesciences newsletter is out lnkd.in/eVzTWaax with info about our new #competitionlaw expert, Kate Newman, and a fascinating discussion of #techbio featuring Dr Raminderpal Singh and James Fry.

We take a look at the #WindsorFramework and what it means for #lifesciences mills-reeve.com/insights/blogs…

e-update.mills-reeve.com/143/2613/novem…

🧬 We’re excited to announce that we have sequenced the whole genomes of 500,000 UK Biobank volunteers! 🧬 The dataset is the world’s largest of its kind and we’re proud to make it available to approved researchers around the world 🌍 ow.ly/qsyy50QcJ7w #500KGenomes

Fascinating discussion of getting innovative therapies to the people that need them @SteBioCat Life Science Integrates #advancedtherapies #lifesciences

Interesting points at Life Science Integrates #AdvancedTherapiesIntegrates2023 - what is getting in the way of efficient research and progress? Ideas include data protection law, reimbursement models.

Are we getting to the point where aspects of advanced therapies manufacturing are becoming standardised and streamlined? #advancedtherapiesintegrates2023

At #advancedtherapiesintegrates2023 hearing about the impact of critical mass and positive results for early products for #ATMPs @SteBioCat

Building partnerships to support and speed up your product development journey. What’s important? Capability, culture (“culture eats strategy for lunch”), value. #ATMPs #advancedtherapiesintegrates2023 @SteBioCat Life Science Integrates

Artificial intelligence (AI) is increasingly able to perform tasks that normally require human intelligence. But, what are the legal challenges around the use of AI in life sciences? Read Isabel Teare's article to find out. #AI #Technology #LifeSciences medhealthoutlook.com/use-of-ai-in-t…

Mills & Reeve intellectual property expert Mark Pearce looks at implications for the use of #AI in #lifesciences lnkd.in/eHD7mjcF